반응형

 

구분 보고서 (영문)
 
제약/바이오/
임상시험		 BMS's Breyanzi Sets New Standards as the First CAR T-Cell Therapy for CLL and SLL
CRISPR-Based Assay Could Revolutionize Diagnosis of NTM Infections
Pfizer’s Velsipity UK Approval Raises Competition in the Ulcerative Colitis Market
Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023
Europe Continues to Have the Most Pollen Allergy Clinical Trials
Rare Disease Pipeline Analysis 2023
Oncology Leads Trials for 2023 with More Than 52% of Trials in Phase II
Nanoscope Therapeutics Exhibits Positive Top-Line Phase IIb Results for MCO-010
Antibody-Drug Conjugates (ADC): Market Overview
Rubraca Sheds Positive Light for PARP Inhibitors in Endometrial Cancer
MASH Revival with Over $2.5 Billion for Innovator Drug Partnership Deals in 2024
Lenmeldy Becomes the World’s Most Expensive Drug at a Wholesale Acquisition Cost of $4 million
FDA Nod Makes Enhertu an Option for Multiple Tumor Indications
Surges in Obesity Drugs Forecast to Enter US Market
질환별 After Decades of Waiting, Late-Stage Therapies May Penetrate the COPD Market This Year
Experts Flag Concerns with Drug Compliance in Osteoporosis Landscape
Cell & Gene Therapies in Ophthalmology
Fuchs Endothelial Corneal Dystrophy (FECD):Competitive Landscape
Rheumatoid Arthritis: Competitive Landscape
Peripheral Artery Disease: Competitive Landscape
Retinitis Pigmentosa: Competitive Landscape
Resistant hypertension: Competitive Landscape
컨퍼런스/
심포지엄/
학회/기타		 World Tuberculosis Day 2024: New Vaccines Needed to Tackle Disease Burden
Cheap Drugs, Inspections, and a Future War in Europe – What’s Really Driving Drug Shortages?
CRISPR Drug Licensing Deals Secure $21 Billion in Top 3 Therapy Areas Over 5 Years
The Wolbachia Method in the Battle Against Dengue
반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.10. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.24. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 3.28.(목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.08.02
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.03.15
반응형

​

　 보고서 (영문)
제약/바이오/
임상시험		 Janssen Gains Approval for Rybrevant as First-Line Treatment for NSCLC Subtype
Innovent’s ROS1 TKI Is One Step Closer to Winning the Chinese NSCLC Market
FLOW Trial Sheds Positive Light on Ozempic for CKD
GLP1 Agonists to Surpass PD1 Antagonists as the Best Selling Drugs in 2024 and Beyond
IO360: Phase II Trial Reveals Motixafortide's Efficacy in First-Line Pancreatic Cancer Treatment
RNA-Based Drugs and the Impact of COVID-19
Eli Lilly’s Partnership with Amazon to Boost Presence in Diabetes and Obesity Markets
Padcev, Keytruda, and Balversa Leave Little Room for Opdivo in Urothelial Carcinoma
질환별 Polycystic Ovarian Syndrome: Competitive Landscape
Cases of Tuberculosis Could Exceed Pre-Pandemic Numbers in England
TB Potentially Transmissible in Undiagnosed Cases
Cell & Gene Therapies in CNS Disorders
Artificial Intelligence Identified Two Evolutionary Pathways of Prostate Cancer
Female Vitiligo Patients Are at an Increased Risk of Osteoporosis
Lung Cancer Deaths Have Declined Sharply in UK Middle-Aged Adults
컨퍼런스/
심포지엄/
학회/기타		 AD/PD 2024: Early Diagnosis Remains a Hurdle for DMT in Parkinson’s
AD/PD 2024: The Role of Blood-Based Biomarkers in Alzheimer’s Disease
AD/PD 2024: Promise for TauRx’s HMTM, Despite Lacking Primary Endpoint Data
AD/PD 2024: Cell Therapies Show Promise for Parkinson’s Disease Non-motor Symptoms
AD/PD 2024: Eli Lilly’s Donanemab Hit with FDA Delay
AD/PD 2024: Leqembi Data Supports Early Treatment Initiation for Better Outcomes
AD/PD 2024: BioVie’s Novel NE3107 Shows Promise but Confirmatory Trial Needed
AD/PD 2024: Exploring Cutting-Edge Therapies for Amyotrophic Lateral Sclerosis
Defining the HTA Landscape for France and Germany: 2019–23
Highlights from the IO360 Conference: PD-1 Inhibitors and Systemic Oncolytic Viral Immunotherapies
New NIH Cancer Screening Research Network to Evaluate Screening Technologies
BIOSECURE Act Could Impact WuXi-Manufactured Drugs for the US Market
Clinical Trial Decline Highlights a Lack of Incentives for Drug Manufacturers



반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.24. (수)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.12. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.08.02
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.03.15
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.03.15
반응형

 

구분 보고서(영문)
제약/
바이오/
임상시험
(11건)		 AbbVie’s Humira Loss of Exclusivity Has Been a Missed Opportunity for Competitors
J&J Forecast to Dominate BiTE Market
2-SUCCEED Trial Sheds Positive Light on SC0062 for IgAN
Small but Mighty, mRNA Vaccines Enter H5N1
J&J’s Carvykti to Make a Meteoric Rise in Multiple Myeloma
Pipeline Power: Sionna’s AbbVie Deal Could Redefine CF Therapeutics
Paratek’s Nuzyra Exhibits Continued Clinical Success Following Phase III Study
NewAmsterdam’s Obicetrapib Holds Potential to Become First CETP Inhibitor to Advance to Clinical Practice
Viking Therapeutics’s New Dual GLP-1R/GIPR Agonist Expected to Start Phase III Clinical Trials Soon
Novo’s Growth Faces Challenges Despite GLP-1 Receptor Agonist Obesity Boom
Clinical Trials: Psychedelic Therapeutics
컨퍼런스/
심포지엄/
학회/
기타
(3건)		 The US Biosecure Act Threatens to Destabilize the Pharmaceutical Industry
FDA’s Diversity Action Plan May Set a New Paradigm for Trial Transparency
Monthly Macroeconomic Forecast - July 2024
질환별
(11건)		 Renal Cell Carcinoma (RCC): Epidemiology Forecast to 2033
Spinal Muscular Atrophy Market Expected to Reach $3.0 Billion Across the 7MM by 2033
US Study Explores Racial Disparities in the Treatment of Type 2 Diabetes
High Caseload of Dengue in New York and New Jersey
Multiple Myeloma Eight-Market Drug Forecast
Irregular Sleeping Pattern Increases the Risk of Type 2 Diabetes
Alcoholic Hepatitis: Competitive Landscape
Non-Hodgkin’s Lymphoma Trials Increase Over Past 5 Years
New AI Model Boosts Early Osteoporosis Diagnosis for Aging Populations
Migraine: Epidemiology Forecast to 2033
US Launches Campaign to Address Racial Disparities in Lung Cancer Biomarker Testing

 

반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 4.12. (금)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 3.28.(목)  (0) 2024.09.15
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.03.15
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.03.15
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.03.15
반응형

 

구분 보고서 (영문)
제약/바이오/임
상시험		 Takeda’s Eohilia to Compete Sanofi’s Dupixent in Eosinophilic Esophagitis Treatment
eConsent: The Overlooked Patient-Centric Tool
The Magrolimab Trial Halt Highlights the Uncertainties in Anti-CD47 Immunotherapy
The Tiny Pills That May Send Shockwaves Across Immunology
Cell and Gene Therapy Landscape in the US
Another Setback for Minerva’s Schizophrenia Treatment Roluperidone
APAC Led in Trials for 2023, with the Majority in Phase II
Oncology Emerges as Dominant Therapy Area for
CRISPR Technology
Allecra’s EXBLIFEP Provides Valuable New Weapon to Tackle ESBL Mediated AMR
AbbVie and Genmab’s Epkinly Joins BiTE Competition in Follicular
Lymphoma
질환별 Comorbidities Associated with ADHD Present an Opportunity for Pipeline Products to Capture the Market
Female Sexual Dysfunction: Competitive Landscape
Shifting the Paradigm – Novel Approaches to Amyotrophic Lateral Sclerosis Therapy
Cell & Gene Therapies in Hemophilia A & B
Shifting Patterns in Cervical Cancer Cases in Women in Their 30s and 40s
컨퍼런스/심포
지엄/학회/기타		 IO360: First Allogeneic Dual CAR T-Cell Therapy Shows Promise in B Cell Non-Hodgkin Lymphom
Biotech Funding Optimism Rises as 44% Predict Recovery in 2024
Market Cap Upturn for Top 20 Biopharma Companies with Obesity Drug Successes in 2023
AD/PD 2024: The Role of Blood-Based Biomarkers in
Alzheimer’s Disease
AD/PD 2024: Promising Data for Monitoring Speech Deficits in Early
Parkinson’s 
반응형
저작자표시

'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글

해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 3.28.(목)  (0) 2024.09.15
해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.08.02
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.03.15
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트  (0) 2024.03.15
[KoNECT] 해외 임상시험 정보 데이터(GlobalData) 보고서  (0) 2024.03.15

+ Recent posts

티스토리툴바